These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 22317767

  • 1. Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.
    Chu H, Wang M, Yan F, Zhong D, Shi D, Ma L, Pan X, Qin C, Yin C, Zhang Z.
    Ann Oncol; 2012 Aug; 23(8):2114-2121. PubMed ID: 22317767
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Associations of IL-4, IL-4R, and IL-13 gene polymorphisms in coal workers' pneumoconiosis in China: a case-control study.
    Wang M, Wang S, Song Z, Ji X, Zhang Z, Zhou J, Ni C.
    PLoS One; 2011 Aug; 6(8):e22624. PubMed ID: 21857939
    [Abstract] [Full Text] [Related]

  • 5. IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.
    Zhu J, Qin C, Yan F, Wang M, Ding Q, Zhang Z, Yin C.
    Int J Urol; 2010 Aug; 17(8):700-7. PubMed ID: 20529140
    [Abstract] [Full Text] [Related]

  • 6. Association of IL-4 -590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population.
    Zhu J, Ju X, Yan F, Qin C, Wang M, Ding Q, Zhang Z, Yin C.
    Int J Immunogenet; 2010 Dec; 37(6):459-65. PubMed ID: 20618516
    [Abstract] [Full Text] [Related]

  • 7. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
    Liu GX, Zhang X, Li S, Koiiche RD, Sindsceii JH, Song H.
    Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
    [Abstract] [Full Text] [Related]

  • 8. The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma.
    Chang WS, Liao CH, Tsai CW, Hu PS, Wu HC, Hsu SW, Ji HX, Hsiao CL, Bau DT.
    Anticancer Res; 2016 May; 36(5):2205-9. PubMed ID: 27127124
    [Abstract] [Full Text] [Related]

  • 9. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
    Arjumand W, Ahmad ST, Nafees S, Ali N, Rashid S, Seth A, Sultana S.
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
    [Abstract] [Full Text] [Related]

  • 10. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population.
    Nakamura E, Megumi Y, Kobayashi T, Kamoto T, Ishitoya S, Terachi T, Tachibana M, Matsushiro H, Habuchi T, Kakehi Y, Ogawa O.
    Clin Cancer Res; 2002 Aug; 8(8):2620-5. PubMed ID: 12171893
    [Abstract] [Full Text] [Related]

  • 11. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.
    Clin Cancer Res; 2007 Jul 15; 13(14):4123-9. PubMed ID: 17634539
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population.
    Wang Z, Xu Y, Zhu S.
    Int J Clin Exp Pathol; 2015 Jul 15; 8(11):15228-33. PubMed ID: 26823871
    [Abstract] [Full Text] [Related]

  • 13. Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma.
    Chang WS, Shen TC, Yeh WL, Yu CC, Lin HY, Wu HC, Tsai CW, Bau DT.
    Int J Mol Sci; 2019 Mar 28; 20(7):. PubMed ID: 30925760
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
    Ferreira M, Teixeira A, Maurício J, Lobo F, Morais A, Medeiros R.
    Urol Oncol; 2017 Aug 28; 35(8):532.e25-532.e30. PubMed ID: 28476527
    [Abstract] [Full Text] [Related]

  • 15. Impact of Vascular Endothelial Growth Factor Gene Polymorphisms and Their Interactions with Environmental Factors on Susceptibility to Renal Cell Carcinoma.
    Liu F, Wen T, Tang Q, Chen F, Liao D.
    Nephron; 2020 Aug 28; 144(5):255-260. PubMed ID: 32182617
    [Abstract] [Full Text] [Related]

  • 16. Association of hypoxia-inducible factor-1 alpha gene polymorphism with renal cell carcinoma susceptibility.
    Huang L, Li MQ, Ou C, Huang WC, Liu JF, Huang H.
    J Cancer Res Ther; 2018 Dec 28; 14(Supplement):S1105-S1109. PubMed ID: 30539853
    [Abstract] [Full Text] [Related]

  • 17. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST, Arjumand W, Seth A, Nafees S, Rashid S, Ali N, Hamiza OO, Sultana S.
    Urol Oncol; 2013 Oct 28; 31(7):1350-7. PubMed ID: 22281432
    [Abstract] [Full Text] [Related]

  • 18. Renal cell carcinoma risk is associated with the interactions of APOE, VHL and MTHFR gene polymorphisms.
    Lv C, Bai Z, Liu Z, Luo P, Zhang J.
    Int J Clin Exp Pathol; 2015 Oct 28; 8(5):5781-6. PubMed ID: 26191297
    [Abstract] [Full Text] [Related]

  • 19. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
    Xian W, Zheng H, Wu WJ.
    Genet Mol Res; 2015 Jul 13; 14(3):7634-42. PubMed ID: 26214443
    [Abstract] [Full Text] [Related]

  • 20. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
    Chang WS, Tsai CW, Wang SM, Wang SW, Wu HC, Ji HX, Lin CH, Wang ZH, Chou JC, Bau DT, Wang PS.
    Chin J Physiol; 2014 Aug 31; 57(4):220-6. PubMed ID: 25246063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.